Charles River Laboratories | CRL - Trade Creditors

Stock Price
188.00
Daily Change
-13.62 -6.76%
Monthly
-13.01%
Yearly
13.07%
Q1 Forecast
204.00

Charles River Laboratories reported $169.61M in Trade Creditors for its fiscal quarter ending in September of 2025.





Trade Creditors Change Date
Agilent USD 570M 40M Sep/2025
Align Technology USD 121.45M 4.1M Dec/2025
Bio-Rad Laboratories USD 128.8M 10.5M Sep/2025
Bruker USD 184.4M 58.6M Sep/2025
Cardinal Health USD 39B 2.14B Dec/2025
Charles River Laboratories USD 169.61M 23.82M Sep/2025
Cigna USD 9.35B 592M Sep/2025
CVS Health USD 60.95B 2.08B Sep/2025
Danaher USD 1.84B 147M Dec/2025
Dentsply International USD 268M 0 Sep/2025
Elevance Health USD 17.08B 64M Dec/2025
Galapagos EUR 100.63M 32.55M Sep/2025
Hologic USD 201.1M 573.5M Dec/2025
Humana USD 5.52B 11.13B Sep/2025
Illumina USD 218M 18M Sep/2025
Incyte USD 171.92M 1.24B Sep/2025
IQVIA Holdings USD 3.75B 201M Dec/2025
Laboratory Of America USD 668.5M 124.5M Sep/2025
Lonza CHF 471M 3M Dec/2024
McKesson USD 60.68B 255M Dec/2025
Merck EUR 1.93B 32M Sep/2025
Mettler Toledo International USD 247.4M 31.22M Sep/2025
Novartis USD 4.56B 49M Sep/2025
Pfizer USD 5.02B 142M Sep/2025
Quest Diagnostics USD 1.46B 108M Sep/2025
Revvity USD 175.8M 2.35M Sep/2025
Thermo Fisher Scientific USD 3.12B 140M Sep/2025
United Therapeutics USD 468M 36M Sep/2025
UnitedHealth USD 40.18B 1.75B Sep/2025
Waters USD 115.73M 17.82M Sep/2025
West Pharmaceutical Services USD 255.8M 16.8M Sep/2025